$CATX
Perspective Therapeutics, Inc. Stock $catx

$catx Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000114420417007073 Filed on February 09, 2017

Income Statement

Concept	2016 Q4	2015 Q4
Revenue	$1.028M	$1.189M
YoY Change	-13.54%	11.58%
Cost Of Revenue	$1.029M	$1.162M
YoY Change	-11.45%	5.3%
Gross Profit	-$1.000K	$30.00K
YoY Change	-103.33%	-179.02%
Gross Profit Margin	-0.1%	2.52%
Selling, General & Admin	$1.376M	$1.379M
YoY Change	-0.22%	63.83%
% of Gross Profit		4596.67%
Research & Development	$150.0K	$58.00K
YoY Change	158.62%	-58.76%
% of Gross Profit		193.33%
Depreciation & Amortization	$20.00K	$137.5K
YoY Change	-85.46%	1.74%
% of Gross Profit		458.44%
Operating Expenses	$1.478M	$1.437M
YoY Change	2.85%	46.28%
Operating Profit	-$1.479M	-$1.410M
YoY Change	4.89%	38.19%
Interest Expense	$30.00K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$29.00K	$99.00K
YoY Change	-70.71%	-12.67%
Pretax Income	-$1.450M	-$1.310M
YoY Change	10.69%	43.96%
Income Tax
% Of Pretax Income
Net Earnings	-$1.450M	-$1.312M
YoY Change	10.52%	44.66%
Net Earnings / Revenue	-141.05%	-110.34%
Basic Earnings Per Share
Diluted Earnings Per Share	-$26.35K	-$23.81K
COMMON SHARES
Basic Shares Outstanding	55.02M shares	55.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.95M	$12.60M
YoY Change	-5.16%	10.72%
Cash & Equivalents	$6.668M	$679.0K
Short-Term Investments	$5.280M	$11.92M
Other Short-Term Assets	$220.0K	$220.0K
YoY Change	0.0%	0.0%
Inventory	$380.0K	$476.7K
Prepaid Expenses
Receivables	$630.0K	$980.0K
Other Receivables	$0.00	$8.715K
Total Short-Term Assets	$13.18M	$14.28M
YoY Change	-7.73%	11.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$779.0K	$335.8K
YoY Change	132.02%	-55.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$5.160M
YoY Change	-100.0%	-48.91%
Other Assets	$278.0K	$233.0K
YoY Change	19.31%	-7.13%
Total Long-Term Assets	$1.806M	$6.461M
YoY Change	-72.05%	-45.06%
TOTAL ASSETS
Total Short-Term Assets	$13.18M	$14.28M
Total Long-Term Assets	$1.806M	$6.461M
Total Assets	$14.99M	$20.74M
YoY Change	-27.76%	-15.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$310.0K	$680.0K
YoY Change	-54.41%	38.78%
Accrued Expenses	$560.0K	$400.0K
YoY Change	40.0%	-11.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$871.0K	$1.079M
YoY Change	-19.26%	14.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$550.0K	$1.110M
YoY Change	-50.45%	-0.89%
Total Long-Term Liabilities	$550.0K	$1.110M
YoY Change	-50.45%	-0.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$871.0K	$1.079M
Total Long-Term Liabilities	$550.0K	$1.110M
Total Liabilities	$1.418M	$2.193M
YoY Change	-35.34%	6.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.39M	-$64.06M
YoY Change	8.32%	7.23%
Common Stock	$82.96M	$82.62M
YoY Change	0.4%	150441.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$8.390K
YoY Change		0.0%
Treasury Stock Shares		13.20K shares
Shareholders Equity	$13.57M	$18.55M
YoY Change
Total Liabilities & Shareholders Equity	$14.99M	$20.74M
YoY Change	-27.76%	-15.62%

Cashflow Statement

Concept	2016 Q4	2015 Q4
OPERATING ACTIVITIES
Net Income	-$1.450M	-$1.312M
YoY Change	10.52%	44.66%
Depreciation, Depletion And Amortization	$20.00K	$137.5K
YoY Change	-85.46%	1.74%
Cash From Operating Activities	-$1.660M	-$810.0K
YoY Change	104.94%	30.65%
INVESTING ACTIVITIES
Capital Expenditures	-$90.00K	-$30.00K
YoY Change	200.0%	-25.0%
Acquisitions
YoY Change
Other Investing Activities	-$30.00K	-$50.00K
YoY Change	-40.0%	-28.57%
Cash From Investing Activities	-$120.0K	-$80.00K
YoY Change	50.0%	-27.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	-10.00K
YoY Change	0.0%	0.0%
NET CHANGE
Cash From Operating Activities	-1.660M	-810.0K
Cash From Investing Activities	-120.0K	-80.00K
Cash From Financing Activities	-10.00K	-10.00K
Net Change In Cash	-1.790M	-900.0K
YoY Change	98.89%	21.62%
FREE CASH FLOW
Cash From Operating Activities	-$1.660M	-$810.0K
Capital Expenditures	-$90.00K	-$30.00K
Free Cash Flow	-$1.570M	-$780.0K
YoY Change	101.28%	34.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	224000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	304000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	13179000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	13629000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	779000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	577000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2016Q2	us-gaap	Long Term Investments LongTermInvestments	2973000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000	USD
CY2016Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	568000	USD
CY2016Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	591000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	278000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	151000	USD
CY2016Q4	us-gaap	Assets Assets	14985000	USD
CY2016Q2	us-gaap	Assets Assets	18102000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	312000	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	612000	USD
CY2016Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	122000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	195000	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	177000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	90000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	72000	USD
CY2016Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	118000	USD
CY2016Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	111000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	871000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1094000	USD
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2016Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	27000	USD
CY2016Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	547000	USD
CY2016Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	580000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1418000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	1701000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82901000	USD
CY2016Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	156000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69389000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	13567000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14985000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1028000	USD
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1189000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1029000	USD
CY2015Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1162000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	-1000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	27000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	150000	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58000	USD
CY2016Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	496000	USD
CY2015Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	254000	USD
CY2016Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	880000	USD
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1125000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	1478000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	1437000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1479000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1410000	USD
CY2016Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	29000	USD
CY2015Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	56000	USD
CY2016Q4	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2015Q4	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	43000	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	99000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-1450000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-1311000	USD
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1452000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1314000	USD
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2016Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55017000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55014000	shares
CY2016Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2015Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2947000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2331000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	274000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	23000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	28000	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	15000	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	43000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	122000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	63000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-74000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	73000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-79000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-73000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-299000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	183000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	34000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-45000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	18000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	24000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	18000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-140000	USD
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	7000	USD
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-35000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3014000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1920000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	239000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35000	USD
CY2016Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	155000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	193000	USD
CY2016Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	161000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	21000	USD
CY2016Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8335000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8118000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7556000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7541000	USD
CY2016Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52000	USD
CY2015Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	122000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	63000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M20D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2565000	shares
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	151000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3527000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	58000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	6140000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-448000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2664000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	47000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-9000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	36000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3471000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4548000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5227000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	679000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	isr	Federal Deposit Insurance Corporation Limits On Deposits In Financial Institutions FederalDepositInsuranceCorporationLimitsOnDepositsInFinancialInstitutions	250000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2629000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2546000	shares
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	167000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2492000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1615000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.07
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.06
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.09
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M29D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y5M26D
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	83000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	82000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	82000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6800	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	20000	shares
CY2016Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	3537500	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6668000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	10139000	USD
CY2016Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	27000	USD
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	230087	shares
	isr	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	225087	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5000	shares
CY2016Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.94
CY2016Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.98
	isr	Classofwarrantorrightexpiredinperiodweightedaverageexercisepriceofwarrantsorrights Classofwarrantorrightexpiredinperiodweightedaverageexercisepriceofwarrantsorrights	0.94
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	55000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	55000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7001671	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7001671	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	192998329	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	192998329	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55017419	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55017419	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55010619	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55010619	shares
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2109000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2450000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2062000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2340000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	322000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	202000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1020000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	533000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1807000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1876000	USD
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	48000	USD
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	0	USD
	us-gaap	Operating Expenses OperatingExpenses	3101000	USD
	us-gaap	Operating Expenses OperatingExpenses	2611000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3054000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2501000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	60000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	112000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	27000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	58000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	20000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	107000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	170000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2952000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2336000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55014000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55013000	shares
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000	USD
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 48px"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <b>2.</b></font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt"> <b>New Accounting Pronouncements</b></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, "Revenue from Contracts with Customers" (ASU 2014-09), which supersedes the revenue recognition requirements in FASB Accounting Standards Codification (ASC) Topic 605, "Revenue Recognition". The guidance requires that an entity recognize revenue in a way that depicts the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. The guidance will be effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, and is to be applied retrospectively, with early application not permitted. The Company continues to evaluate the new standard and its impact on the Company's consolidated financial statements. This update will be effective as of the beginning of fiscal 2019. This update is not expected to have a material impact on the Company’s consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In July 2015, the FASB issued ASU No. 2015-11: Inventory. The guidance requires an entity’s management to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early application is permitted.  The Company continues to evaluate the new standard and its impact on the Company's consolidated financial statements. This update will be effective as of the beginning of fiscal 2018.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In November 2015, the FASB issued ASU 2015-17 to simplify the balance sheet classification of deferred taxes. This update requires all deferred tax assets and liabilities to be reported as non-current in the consolidated balance sheets. This update will be effective as of the beginning of fiscal 2018. This update is not expected to have a material impact on the Company’s consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In February 2016, the FASB issued ASU 2016-02 Leases (Subtopic 842), which will require lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases. The update is effective for annual and interim reporting periods beginning after December 15, 2018. The Company continues to evaluate the new standard and its impact on the Company's consolidated financial statements. This update will be effective as of the beginning of fiscal 2019.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. Except to indicate an evaluation of a recent pronouncement is in process, the Company does not discuss recent pronouncements that are not anticipated to have potential impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures of the Company.   </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	645000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M18D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	45994	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	22000	USD
CY2015Q4	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	0	USD
CY2016Q4	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	48000	USD
	us-gaap	Gross Profit GrossProfit	47000	USD
	us-gaap	Gross Profit GrossProfit	110000	USD
CY2016Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2000	USD
CY2015Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3000	USD
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	4000	USD
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	24000	USD
	isr	Purchase Obligation Expiration Date PurchaseObligationExpirationDate	2017-03-31
	isr	Purchase Obligation Agreement Period PurchaseObligationAgreementPeriod	P1Y
CY2016Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2021-04-30
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	140000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	281000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	281000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	281000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	234000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1217000	USD
	isr	Gain On Change In Aro Estimate GainOnChangeInAroEstimate	-48000	USD
	isr	Gain On Change In Aro Estimate GainOnChangeInAroEstimate	0	USD
CY2016Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	547000	USD
CY2015Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	991000	USD
CY2016Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	580000	USD
CY2015Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	948000	USD
CY2016Q4	isr	Dividends Payable Preferred Stock DividendsPayablePreferredStock	0	USD

Files In Submission

Name	View Source	Status
0001144204-17-007073-index-headers.html	Edgar Link	pending
0001144204-17-007073-index.html	Edgar Link	pending
0001144204-17-007073.txt	Edgar Link	pending
0001144204-17-007073-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
isr-20161231.xml	Edgar Link	completed
isr-20161231.xsd	Edgar Link	pending
isr-20161231_cal.xml	Edgar Link	unprocessable
isr-20161231_def.xml	Edgar Link	unprocessable
isr-20161231_lab.xml	Edgar Link	unprocessable
isr-20161231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v456945_10q.htm	Edgar Link	pending
v456945_ex10-1.htm	Edgar Link	pending
v456945_ex10-2.htm	Edgar Link	pending
v456945_ex31-1.htm	Edgar Link	pending
v456945_ex31-2.htm	Edgar Link	pending
v456945_ex32.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CATX
Perspective Therapeutics, Inc. Stock $catx

2016 Q4 Form 10-Q Financial Statement

#000114420417007073 Filed on February 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX Perspective Therapeutics, Inc. Stock $catx

2016 Q4 Form 10-Q Financial Statement

#000114420417007073 Filed on February 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX
Perspective Therapeutics, Inc. Stock $catx